Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Arjun Agarwal

President at Oruka Therapeutics, Inc. (ORKA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.3M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 21SEC ORKAOruka Therapeutics, Inc. Sell Plan 53314,219 held (−4%) $95.75 $51K -14.2%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 3,00021,771 held (−12%) $91.11 $273K -9.9%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 4,05117,720 held (−19%) $92.41 $374K -11.1%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 2,20815,512 held (−12%) $93.26 $206K -12.0%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 20015,312 held (−1%) $94.02 $19K -12.7%
Sep 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 56014,752 held (−4%) $95.71 $54K -14.2%
Aug 14SEC ORKAOruka Therapeutics, Inc. Sell Plan 2,10023,212 held (−8%) $104.67 $220K -21.6%
Aug 14SEC ORKAOruka Therapeutics, Inc. Sell Plan 2,13221,080 held (−9%) $105.57 $225K -22.2%
Aug 14SEC ORKAOruka Therapeutics, Inc. Sell Plan 1,26819,812 held (−6%) $106.63 $135K -23.0%
Aug 14SEC ORKAOruka Therapeutics, Inc. Sell Plan 2,14217,670 held (−11%) $107.71 $231K -23.8%
Aug 14SEC ORKAOruka Therapeutics, Inc. Sell Plan 2,35815,312 held (−13%) $108.46 $256K -24.3%
Jul 13SEC ORKAOruka Therapeutics, Inc. Sell Plan 30025,011 held (−1%) $83.07 $25K -1.2%
Jul 13SEC ORKAOruka Therapeutics, Inc. Sell Plan 3,74321,268 held (−15%) $84.26 $315K -2.6%
Jul 13SEC ORKAOruka Therapeutics, Inc. Sell Plan 5,65615,612 held (−27%) $84.90 $480K -3.3%
Jul 13SEC ORKAOruka Therapeutics, Inc. Sell Plan 30015,312 held (−2%) $85.63 $26K -4.1%
Jun 22SEC ORKAOruka Therapeutics, Inc. Sell Plan 88816,011 held (−5%) $80.01 $71K +2.6%
Jun 22SEC ORKAOruka Therapeutics, Inc. Sell Plan 69915,312 held (−4%) $82.15 $57K -0.0%
Jun 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 1,85924,894 held (−7%) $68.34 $127K +20.1%
Jun 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 4,34020,554 held (−17%) $69.85 $303K +17.6%
Jun 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 3,26017,294 held (−16%) $70.34 $229K +16.7%
Jun 15SEC ORKAOruka Therapeutics, Inc. Sell Plan 39516,899 held (−2%) $69.69 $28K +17.8%
May 18SEC ORKAOruka Therapeutics, Inc. Sell Plan 4,19022,506 held (−16%) $58.34 $244K +40.7%
May 18SEC ORKAOruka Therapeutics, Inc. Sell Plan 4,60017,906 held (−20%) $59.19 $272K +38.7%
May 18SEC ORKAOruka Therapeutics, Inc. Sell Plan 80017,106 held (−4%) $60.34 $48K +36.1%
May 18SEC ORKAOruka Therapeutics, Inc. Sell Plan 70016,406 held (−4%) $61.16 $43K +34.3%
Mar 17SEC ORKAOruka Therapeutics, Inc. Sell 39518,863 held (−2%) $41.30 $16K +98.8%
  • Sell

    President Arjun Agarwal sold $51K of ORKA at $95.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Arjun Agarwal sold $273K of ORKA at $91.11 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Arjun Agarwal sold $374K of ORKA at $92.41 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Arjun Agarwal sold $206K of ORKA at $93.26 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Arjun Agarwal sold $19K of ORKA at $94.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    President Arjun Agarwal sold $54K of ORKA at $95.71 — pre-scheduled 10b5-1 plan sale.